Average Co-Inventor Count = 4.91
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-Myers Squibb Compnay (10 from 3,685 patents)
2. Astrazeneca Ab (1 from 1,501 patents)
11 patents:
1. 8809024 - Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor
2. 8361761 - Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor
3. 8222009 - Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor
4. 7741082 - Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor
5. 7611880 - Enzymatic ammonolysis process for the preparation of intermediates for DPP IV inhibitors
6. 7223573 - Enzymatic ammonolysis process for the preparation of intermediates for DPP IV inhibitors
7. 6942990 - Glutaryl cephalosporin amidase from Pseudomonas diminuta BS-203
8. 6800465 - D-hydantoinase from Ochrobactrum anthropi
9. 6528300 - Glutaryl cephalosporin amidase from Pseudomonas diminuta BS-203
10. 5869309 - Cephalosporin esterase gene from Rhodosporidium toruloides
11. 5512454 - Enzymatic acylation of 3-hydroxymethyl cephalosporins